More tools:Markets·Screener·Research·Chat

Nexentis Technologies Inc. Common Stock (NXTS) Financial Statements

Nexentis Technologies Inc. Common Stock
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG001T659H9
XNAS · usd
1.67▼ 0.05 (-2.91%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales—
EV / Revenue—
EV / EBITDA
Financial Highlights
Revenue (TTM)—
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin—
Net Debt
Trading Information
Previous Close1.72
Day's Range1.62 – 1.73
52-Week Range0.57 – 23.80
Volume8,026
Avg Volume60.8K
Share Statistics
Shares Outstanding
Employees9
ExchangeXNAS
Listed2009-12-15
Share count as of August 13, 2026
Loading Income Statement…
Key questions about Nexentis Technologies Inc. Common Stock (NXTS)
What is Nexentis Technologies Inc. Common Stock's Market Cap?
Nexentis Technologies Inc. Common Stock's Market Cap is $2.4M, based on as-reported figures from SEC (XBRL) filings.
What is Nexentis Technologies Inc. Common Stock's Enterprise Value?
Nexentis Technologies Inc. Common Stock's Enterprise Value is -$6.2M, based on as-reported figures from SEC (XBRL) filings.
What is Nexentis Technologies Inc. Common Stock's EV / EBITDA?
Nexentis Technologies Inc. Common Stock's EV / EBITDA is 0.6×, based on as-reported figures from SEC (XBRL) filings.
What is Nexentis Technologies Inc. Common Stock's Net Income (TTM)?
Nexentis Technologies Inc. Common Stock's Net Income (TTM) is -$16.0M, based on as-reported figures from SEC (XBRL) filings.
What is Nexentis Technologies Inc. Common Stock's EBITDA?
Nexentis Technologies Inc. Common Stock's EBITDA is -$10.9M, based on as-reported figures from SEC (XBRL) filings.
What is Nexentis Technologies Inc. Common Stock's Diluted EPS (TTM)?
Nexentis Technologies Inc. Common Stock's Diluted EPS (TTM) is -11.03, based on as-reported figures from SEC (XBRL) filings.
What is Nexentis Technologies Inc. Common Stock's Net Debt?
Nexentis Technologies Inc. Common Stock's Net Debt is -$8.7M, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Operating expenses:
Research and development expenses
General and administrative expenses, exclusive of depreciation and amortization
Change in fair value of contingent consideration——
Depreciation and amortization——
Operating loss
Financing expense, net——
Non-Operating Income (Expense)—
Gain/Loss on Investments
Net loss before tax——
Net loss
Less: Net loss attributable to non-controlling interests
Net loss attributable to the Company’s stockholders’ equity
Earnings Per Share (Basic)—
Earnings Per Share (Diluted)—